Molnupiravir against Covid

Molnupiravir against Covid (Bloomberg).  It might cut the death rate in half, the market has been boosting the Merck share price.  And more here: “…molnupiravir works by introducing genetic errors that garble the coronavirus’s genetic code. That means it may be more resistant to mutation, and may even work on other coronaviruses or RNA viruses.”  And StatNews here.


Comments for this post are closed